OncoSec Medical Incorporated
7 clinical trials · Sponsor
◉ Watch OncoSec Medical Incorporated
| Record | Firm | Date |
|---|---|---|
| Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC (NCT03567720) | OncoSec Medical Incorporated | 2018-10-11 |
| Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Either Pembrolizumab or Nivolumab Treatment (NCT03132675) | OncoSec Medical Incorporated | 2017-10-03 |
Track OncoSec Medical Incorporated automatically
Every clearance here is in the API, with alerts when new ones post.